CNTB

Connect Biopharma Holdings
CNTB

Overview Fund Trends Analyst Outlook Journalist POV

13 hedge funds and large institutions have $1.56M invested in Connect Biopharma Holdings in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$5.67K
2
+$2.2K

Top Sellers

1
-$133K
2
-$66.1K
3
-$21.8K
4
GM
GeoWealth Management
Illinois
-$15.1K
5
Renaissance Technologies
Renaissance Technologies
New York
-$10.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
1
BML Capital Management
Indiana
$1.15M
UOC
2
UBS O'Connor
Illinois
$148K
CL
3
Choreo LLC
Illinois
$88.5K
Renaissance Technologies
4
Renaissance Technologies
New York
$63.1K
CC
5
Callan Capital
California
$44K
Royal Bank of Canada
6
Royal Bank of Canada
Ontario, Canada
$22K
Geode Capital Management
7
Geode Capital Management
Massachusetts
$15.4K
Commonwealth Equity Services
8
Commonwealth Equity Services
Massachusetts
$11K
ACM
9
ADAR1 Capital Management
Texas
$5.67K
UBS Group
10
UBS Group
Switzerland
$4.81K
RhumbLine Advisers
11
RhumbLine Advisers
Massachusetts
$1.3K
JPMorgan Chase & Co
12
JPMorgan Chase & Co
New York
$67
SS
13
SBI Securities
Japan
$3
CCG
14
Catalina Capital Group
California
–
GM
15
GeoWealth Management
Illinois
–